We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$3.3M
Cap. Flow
-$3.52M
Cap. Flow %
-2%
Top 10 Hldgs %
34.97%
Holding
113
New
8
Increased
24
Reduced
32
Closed
7

Top Buys

Rank Stock Value
1
SRXH
SRX Global
SRXH
+$1.26M
2
ACHV icon
Achieve Life Sciences
ACHV
+$1.25M
3
BIOL
Biolase, Inc.
BIOL
+$1.09M
4
VVOS icon
Vivos Therapeutics
VVOS
+$1.06M
5
ASPU
ASPEN GROUP, INC.
ASPU
+$1M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$4.36M
2
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$1.92M
3
SHSP
SharpSpring, Inc.
SHSP
+$1.79M
4
SONM icon
DNA X Inc
SONM
+$1.49M
5
INTZ
INTRUSION INC NEW
INTZ
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 61.83%
2 Technology 15.72%
3 Communication Services 6.71%
4 Industrials 4.61%
5 Consumer Staples 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
26
Castle Biosciences
CSTL
$855M
$2.43M 1.38%
33,150
-350
-1% -$23.1K
PERI icon
27
Perion Network
PERI
$375M
$2.4M 1.36%
111,851
+37,851
+51% +$640K
ATRS
28
DELISTED
Antares Pharma, Inc.
ATRS
$2.36M 1.34%
541,783
-500
-0.1% -$2.04K
VG
29
DELISTED
Vonage Holdings Corporation
VG
$2.28M 1.3%
158,525
+2,500
+2% +$34.2K
BIOL
30
DELISTED
Biolase, Inc.
BIOL
$2.18M 1.24%
1,249
+587
+89% +$1.09M
CSII
31
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.13M 1.21%
49,942
-825
-2% -$32.3K
ASPU
32
DELISTED
ASPEN GROUP, INC.
ASPU
$2.1M 1.19%
321,250
+176,000
+121% +$1M
PFE icon
33
Pfizer
PFE
$143B
$1.99M 1.13%
50,848
+1,920
+4% +$74.7K
AKTS
34
DELISTED
Akoustis Technologies Inc
AKTS
$1.95M 1.11%
182,200
+8,750
+5% +$92.4K
TGT icon
35
Target
TGT
$65.6B
$1.89M 1.07%
7,829
– –
PFIE
36
DELISTED
Profire Energy, Inc
PFIE
$1.78M 1.01%
1,572,260
-56,620
-3% -$65.2K
QUIK icon
37
QuickLogic
QUIK
$232M
$1.75M 0.99%
241,785
+8,000
+3% +$52.2K
ZIXI
38
DELISTED
Zix Corporation
ZIXI
$1.62M 0.92%
230,175
-2,500
-1% -$18.1K
XLNX
39
DELISTED
Xilinx Inc
XLNX
$1.56M 0.89%
10,795
– –
ACHV icon
40
Achieve Life Sciences
ACHV
$659M
$1.54M 0.88%
172,100
+131,500
+324% +$1.25M
ELUT icon
41
Elutia
ELUT
$37.9M
$1.48M 0.84%
154,425
+15,500
+11% +$179K
ABBV icon
42
AbbVie
ABBV
$443B
$1.39M 0.79%
12,313
– –
CATX icon
43
Perspective Therapeutics
CATX
$332M
$1.32M 0.75%
165,400
+25,500
+18% +$223K
MMM icon
44
3M
MMM
$90.9B
$1.3M 0.74%
7,841
– –
SRXH
45
SRX Global
SRXH
$26.9M
$1.29M 0.73%
+153
New +$1.26M
RYM
46
RYTHM Inc
RYM
$39.5M
$1.26M 0.72%
35
-3
-8% -$94.2K
T icon
47
AT&T
T
$159B
$1.18M 0.67%
54,256
+433
+0.8% +$9.85K
PDCO
48
DELISTED
Patterson Companies, Inc.
PDCO
$1.12M 0.64%
36,950
+7,575
+26% +$255K
BMY icon
49
Bristol-Myers Squibb
BMY
$133B
$1.1M 0.62%
16,450
– –
GILD icon
50
Gilead Sciences
GILD
$162B
$1.06M 0.6%
15,400
+3,100
+25% +$207K
1
2
3 4 5

Similar funds

SVP
Strategic Value Partners Greenwich, Connecticut $133M AUM
PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return

Perkins Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Perkins Capital Management held 113 positions worth $176M, up 1.9% from $173M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Perkins Capital Management's Q2 2021 filing shows 8 new, 24 increased, 32 reduced and 7 closed positions. Its largest new stake was SRX Global: 153 shares worth $1.29M. The largest sale was Vericel Corp, an estimated $4.36M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q2 2021 buy was SRX Global: 153 shares worth $1.29M.
  • Perkins Capital Management added most to Achieve Life Sciences in Q2 2021, an estimated $1.25M increase.
  • Perkins Capital Management's biggest Q2 2021 reduction was Vericel Corp, cutting an estimated $4.36M.
  • Perkins Capital Management fully exited Biora Therapeutics, Inc. Common Stock in Q2 2021, selling an estimated $1.92M.
  • Perkins Capital Management's ten largest holdings make up 35% of its $176M portfolio in Q2 2021.
  • Perkins Capital Management opened 8 new positions and closed 7 in Q2 2021.
  • Perkins Capital Management's portfolio value rose 1.9% quarter-over-quarter to $176M.

Based on Perkins Capital Management's 13F filing for Q2 2021, filed 28 Jul 2021.